H.pylori Gastritis. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
Conditions
Interventions
Intervention 1: Intervention group 1: Patients will be treated with omeprazole, metronidazole, high-dose amoxicillin, and folic acid over a 14-day period. It should be noted that omeprazole is adminis
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Years to 18 Years
Inclusion criteria
Inclusion criteria: Children with Helicobacter pylori infection who are known to be resistant to the first stage of eradication
Exclusion criteria
Exclusion criteria: Patients who have had a positive history of taking drugs such as antibiotics during the last 4 weeks, Bismuth, proton pump inhibitor, histamine receptor antagonist 2 or non-steroidal anti-inflammatory drug are excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The percentage of patients with Helicobacter pylori antigen in the stool sample is negative. Timepoint: Helicobacter pylori antigen assay is performed within 4 to 6 weeks after completion of treatment. Method of measurement: Helicobacter pylori antigen in stool sample by ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of people with side effects while taking the drug. Timepoint: From the beginning of the drug to the end of the study. Method of measurement: Self-expression of the patient, parents or carers.;Percentage of patients who were fully compliant with medication. Timepoint: Up to 4 weeks after starting the drug. Method of measurement: Self-expression of the patient, parents or carers. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRita Bagherian
Qazvin University of Medical Sciences
Outcome results
None listed